Scorpion envenomation and antivenom therapy

Pediatric Emergency Care

Volumn 27, Issue 7, 2011, Pages 667-675

  Tuuri, Rachel E ^a   Reynolds, Sally ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

antivena; antivenom; scorpion; scorpion envenomation

Indexed keywords

ANTISERUM; MIDAZOLAM; NORADRENALIN; PLACEBO; SCORPION VENOM ANTISERUM; TROPONIN I; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR; SCORPION VENOM; VENOM ANTISERUM; ALACRAMYN; ANTITOXIN; CENTRUROIDES F(AB)2 ANTIVENOM; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PRAZOSIN; RECOMBINANT ANTIBODY;

ANAPHYLAXIS; ANTIGENICITY; ASSISTED VENTILATION; CARDIOTOXICITY; DRUG POTENCY; ENVENOMATION; ERYTHEMA; HEMODYNAMIC MONITORING; HEMOLYSIS; HUMAN; HYDRATION; INCIDENCE; LIVER TOXICITY; LUNG EDEMA; MORBIDITY; MOTONEURON; NEUROTOXICITY; NONHUMAN; PANCREATITIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORPION; SEDATION; SHOCK; TISSUE NECROSIS; ANIMAL; ARTICLE; CHEMISTRY; PATHOPHYSIOLOGY; SPIDER BITE; ADRENERGIC SYSTEM; CHEMICAL COMPOSITION; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; GEOGRAPHIC DISTRIBUTION; INSECT STING; MORTALITY; POISONOUS SCORPION; RESPIRATORY FAILURE; SCORPION ENVENOMATION; SYSTEMIC DISEASE;

ANIMALS; ANTIVENINS; ARACHNIDISM; HUMANS; IMMUNOLOGIC FACTORS; SCORPION VENOMS; SCORPIONS;

EID: 79960671049     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3182228dfa     Document Type: Review

References (64)

1. Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop. 2008;107:71-79.
2. Saucier JR. Arachnid envenomation. Emerg Med Clin North Am. 2004;22:405-422. (Pubitemid 38686298)
3. Boyer LV, Theodorou AA, Berg RA, et al. Antivenom for critically ill children with neurotoxicity form scorpion stings. N Engl J Med. 2009;360:2090-2098.
4. Corona M, Valdez-Cruz NA, Merino E, et al. Genes and peptides from the scorpion Centruroides sculpturatus Ewing, that recognize Na+ channels. Toxicon. 2001;39:1893-1898. (Pubitemid 32971830)
5. Cheng D, Dattaro JA, Yakobi R. Scorpion envenomation. Emedicine. Available at: http://emedicine.medscape.com/article/168230. Accessed August 6, 2010.
6. Bronstein AC, Spyker DA, Cantilena LR, et al. 2008 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 26th annual report. Clin Toxicol. 2009;47:911-1084.
7. Rodriguez de la Vega RC, Possani LD. Overview of scorpion toxin specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon. 2005;46:831-844. (Pubitemid 41735133)
8. Bosmans F, Tytgat J. Voltage gated sodium channel modulation by scorpion alpha toxins. Toxicon. 2007;49(2):142-158. (Pubitemid 46151716)
9. Tan PT, Veeramani A, Srinivasan KN, et al. Scorpion 2: a database for structure-function analysis of scorpion toxins. Toxicon. 2006;47: 356-363. (Pubitemid 43294465)
10. Hahn I, Lewin NA. Arthropods. In: Goldfrank LR, Nelson LS, eds. Goldfranks Toxicologic Emergencies. 8th ed. New York, NY: McGraw-Hill; 2006.
11. Abdel-Haleem AA, Meki AMA, Noaman HA, et al. Serum levels of IL-6 and its soluble receptor, TNF-alpha and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome. Toxicon. 2006;47:437-444. (Pubitemid 43363462)
12. DSuze G, Salazar V, Diaz P, et al. Histopathological changes and inflammatory response induced by Tityus discrepans scorpion venom in rats. Toxicon. 2004;44:851-860. (Pubitemid 39504916)
13. Fukuhara YD, Dellalibera-Joviliano R, Cunha FQ, et al. The kinin system in the envenomation caused by the Tityus serrulatus scorpion sting. Toxicol Appl Pharmacol. 2004;196:390-395. (Pubitemid 38496461)
14. Fukuhara YD, Reis ML, Dellalibera-Joviliano R, et al. Increased plasma levels of IL-1beta, IL-6, IL-8, IL-10, and TNF-alpha in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon. 2003;41:49-55. (Pubitemid 35449160)
15. Espino-Solis GP, Riano-Umbarila L, Becerril B, et al. Antidotes against venomous animals: state of the art and prospectives. J Proteomics. 2009;72:183-199.
16. Antopolsky M, Salameh S, Stalnikowicz R. Need for emergency department observation after scorpion sting: prospective study and review of the literature in the Middle East. Eur J Emerg Med. 2009;16:206-208.
17. Curry SC, Vance MV, Ryan PJ, et al. Envenomation by the scorpion Centruroides sculpturatus. J Toxicol Clin Toxicol. 1984;21:417-449. (Pubitemid 15209431)
18. Berg RA, Tarantino MD. Envenomation by the scorpion Centruroides exilicauda (C sculpturatus): severe and unusual manifestations. Pediatrics. 1991;87:930-933.
19. Bond GR. Antivenom administration for Centruroides scorpion sting: risks and benefits. Ann Emerg Med. 1992;21:788-791.
20. Cupo P, Hering S. Cardiac troponin release after severe scorpion envenoming by Tityus serrulatus. Toxicon. 2002;40(6):823-830. (Pubitemid 34439246)
21. Blum A, Jawabreh S, Gumanovsky M, et al. Scorpion envenomation and myocardial damage. Isr Med Assoc J. 2000;2(4):318-319. (Pubitemid 30662210)
22. Benvenuti L, Douetts K, Cardisi J. Myocardial necrosis after envenomation by the scorpion Tityus serrulatus. Trans R Soc Trop Med Hyg. 2002;96(3):275-276. (Pubitemid 34785063)
23. Das S, Nalini P, Ananthakrishnan S, et al. Scorpion envenomation in children in southern India. J Trop Med Hyg. 1995;98:306-308.
24. Jain MK, Indurkar M, Sastwar V, et al. Myocarditis and multiple cerebral and cerebellar infarction following scorpion sting. J Assoc Physicians India. 2006;54:491-492. (Pubitemid 43824999)
25. Sarkar S, Bhattacharya P, Paswan A. Cerebrovascular manifestations and alteration of coagulation profile in scorpion sting: a case series. Indian J Crit Care Med. 2008;12(1):15-17. (Pubitemid 351791747)
26. Gadwalkar SR, Bushan S, Pramod K, et al. Bilateral cerebellar infarction: a rare complication of scorpion sting. J Assoc Physicians India. 2006;54:581-583. (Pubitemid 44030793)
27. Udayakumar N, Rajendiran C, Srinivasan AV. Cerebrovascular manifestations in scorpion sting: a case series. Indian J Med Sci. 2006;60:241-244. (Pubitemid 43990013)
28. Thacker AK, Lal R, Misra M. Scorpion bite and multiple cerebral infarcts. Neurol India. 2002;50:100-102. (Pubitemid 34441102)
29. Ismail M, Abd-Elsalam A, Ahaidibid MS. Androctonus crassicauda: a dangerous and unduly neglected scorpion. Pharmacological and clinical studies. Toxicon. 1994;32:599-618.
30. Fernandez-Bouzas AF, Morales-Resendiz ML, Llamas-Ibarra F, et al. Brain infarcts due to scorpion stings in children: MRI. Neuroradiology. 2000;42:118-120. (Pubitemid 30122089)
31. Barthawall SP, Agarwal R, Kanna D, et al. Myocarditis and hemiplegia from scorpion bite: a case report. Ind J Med Sci. 1997;51: 115-117.
32. Sofer S, Shalev H, Wizman Z, et al. Acute pancreatitis in children following envenomation by the yellow scorpion Leiurus quinquestriatus. Toxicon. 1991;29:125-128.
33. Joshi S, Shah S, Pichumoni C, et al. Scorpion sting pancreatitis/ pancreatopathy. J Assoc Physicians India. 1999;47(3):352-354.
34. Bartholomew C. Acute scorpion pancreatitis in Trinidad. Br Med J. 1970;1(5697):666-668.
35. Suchard JR. Scorpion envenomation. In: Auerbach PS, ed. Auerbach: Wilderness Medicine. 5th ed. Philadelphia, PA: Mosby-Elsevier; 2007.
36. Bergman N. Clinical description of Parabuthus transvaalicus scorpionism in Zimbabwe. Toxicon. 1997;35:759-771. (Pubitemid 27244052)
37. Ozkan O, Adiguzel S, Yakistiran S, et al. Androctonus crassicauda scorpionism in the Sanliurfa provinces of Turkey. Turkiye Parazitol Derg. 2006;30(3):239-245.
38. Radmanesh M. Androctonus crassicauda sting and its clinical study in Iran. J Trop Med Hyg. 1990;93:323-326. (Pubitemid 20366310)
39. Jalali A, Pipelzadeh MH, Sayedian R, et al. A reviewof epidemiological, clinical and in vitro physiological studies of envenomation by the scorpion Hemiscorpius lepturus (Hemiscorpiidae) in Iran. Toxicon. 2010;55(2-3):173-179. Epub 2009 Sep.
40. Pipelzadeh MH, Dezfulian AR, Taha Jalali M, et al. An epidemiological and a clinical study on scorpionism by the Iranian scorpion Hemiscorpius lepturus. Toxicon. 2007;50:984-992. (Pubitemid 350026578)
41. Shahbazzadeh D, Amirkhani A, Djadid ND, et al. Epidemiological and clinical survey of scorpionism in Khuzestan province, Iran (2003). Toxicon. 2009;53:454-459.
42. Trestrail JH. Scorpion envenomation in Michigan: three cases of toxic encounters with poisonous stow-aways. Vet Hum Tox. 1981;23:8-11.
43. West PL, Hendrickson RG. Scorpions on a plane? A case series of non-endemic envenomations. J Emerg Med. 2009;20:30.
44. Heard K, Omalley GF, Dart RC. Antivenom therapy in the Americas. Drugs. 1999;58:5-15. (Pubitemid 29373883)
45. Bernstein JN. Antidotes in depth: antivenom (scorpion and spider). In: Goldfrank LR, Nelson LS, eds. Goldfranks Toxicologic Emergencies. 8th ed. New York, NY: McGraw-Hill; 2006.
46. Gutierrez JM, Leon G, Lomonte B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet. 2003;42:721-741. (Pubitemid 36976120)
47. LoVecchio F, Welch S, Klemens J, et al. Incidence of immediate and delayed hypersensitivity to Centruroides antivenom. Ann Emerg Med. 1999;34:615-619. (Pubitemid 29510914)
48. LoVecchio F, McBride C. Scorpion envenomations in young children in Central Arizona. J Toxicol Clin Tox. 2003;41:937-940. (Pubitemid 38018483)
49. Vazquez H, Chavez-Haro A, Garcia-Ubbelohde W, et al. Pharmacokinetics of a F(ab)2 scorpion antivenom in healthy human volunteers. Toxicon. 2005;46:797-805. (Pubitemid 41531607)
50. Van Bockstaele F, Holz JB, Revets H. The development of nanobodies for therapeutic actions. Curr Opin Investig Drugs. 2009;10:1212-1224.
51. Riley BD, LoVecchio F, Pizon AF. Lack of scorpion antivenom leads to increased pediatric ICU admissions. Ann Emerg Med. 2006;47:398-399.
52. Dehesa Davila M, Possani LD. Scorpionism and serotherapy in Mexico. Toxicon. 1994;32:1015-1018. (Pubitemid 24263681)
53. Celis A, Gaxiola-Robles R, Sevilla-Godinez E, et al. Tendencia de la mortalidad por picaduras de alacran en Mexico,1979-2003. Rev Panam Salud Publica. 2007;21:373-380. (Pubitemid 350017525)
54. Sofer S, Gueron M. Respiratory failure in children following envenomation by the scorpion Leiurus quinquestriatus: hemodynamic and neurological aspects. Toxicon. 1988;26:931-939. (Pubitemid 18267176)
55. Mazzei de Davila CA, Davila DF, Donis JH, et al. Sympathetic nervous system activation, antivenin administration and cardiovascular manifestations of scorpion envenomation. Toxicon. 2002;40: 1339-1346. (Pubitemid 35239905)
56. De Rezende NA, Dias MB, Campolina D, et al. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions. Am J Trop Med Hyg. 1995;52:277-280.
57. Bawaskar HS, Bawaskar PH. Utility of scorpion antivenin vs prazosin in the management of severe Mesobuthus tamulus (Indian red scorpion) envenoming at rural setting. J Assoc Physicians India. 2007;55:13-21.
58. Abroug F, El Atrous S, Nouira S, et al. Serotherapy in scorpion envenomation: a randomized controlled trial. Lancet. 1999;354:906-909. (Pubitemid 29424021)
59. Freire-Maia L. Peripheral effects of Tityus serrulatus scorpion venom. J Toxicol. 1995;14:423-435.
60. Belghith M, Boussarsar M, Haguiga H, et al. Efficacy of serotherapy in scorpion sting: a matched pair study. Clin Toxicol. 1999;37:51-57. (Pubitemid 29124571)
61. Sofer S, Shahak E, Gueron M. Scorpion envenomation and antivenom therapy. J Pediatr. 1994;124:973-978. (Pubitemid 24184031)
62. Ismail M. The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy. Toxicon. 1994;32:1019-1026. (Pubitemid 24263682)
63. Boyer L, Alagon A, Theodorou A. Antivenom for children with neurotoxicity from scorpion stings. N Engl J Med. 2009;361:632.
64. Available at: http://clinicaltrials.gov/ct2/show/NCT00624078. Accessed September 6, 2010.